PMID- 22948508 OWN - NLM STAT- MEDLINE DCOM- 20130924 LR - 20180816 IS - 1651-2057 (Electronic) IS - 0001-5555 (Linking) VI - 93 IP - 2 DP - 2013 Mar 27 TI - Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma. PG - 144-9 LID - 10.2340/00015555-1428 [doi] AB - Many patients with cutaneous T-cell lymphoma (CTCL) experience severe pruritus. This study evaluated serum levels of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in patients with CTCL. Although serum NGF and BDNF levels in patients with CTCL were not significantly higher than in healthy controls, serum NGF levels in patients with Sezary syndrome were higher than in those with mycosis fungoides and in healthy controls. Enhanced NGF expression by keratinocytes and increased dermal nerve fibres were detected in lesional skin of subjects with Sezary syndrome. Correlations between pruritus in CTCL and serum levels of NGF, BDNF, chemokine (C-C motif) ligand 1 (CCL1), CCL17, CCL26, CCL27, lactate dehydrogenase (LDH), IgE, and soluble interleukin-2 receptor were analysed. Serum CCL1, CCL26, LDH, and IgE levels correlated with pruritus in patients with CTCL. NGF may be associated with increased dermal nerve fibres and pruritus in Sezary syndrome, and CCL1, CCL26, and IgE may be associated with pruritus in CTCL. FAU - Suga, Hiraku AU - Suga H AD - Department of Dermatology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Tokyo, Japan. FAU - Sugaya, Makoto AU - Sugaya M FAU - Miyagaki, Tomomitsu AU - Miyagaki T FAU - Ohmatsu, Hanako AU - Ohmatsu H FAU - Fujita, Hideki AU - Fujita H FAU - Kagami, Shinji AU - Kagami S FAU - Asano, Yoshihide AU - Asano Y FAU - Tada, Yayoi AU - Tada Y FAU - Kadono, Takafumi AU - Kadono T FAU - Sato, Shinichi AU - Sato S LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Sweden TA - Acta Derm Venereol JT - Acta dermato-venereologica JID - 0370310 RN - 0 (Biomarkers, Tumor) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (CCL1 protein, human) RN - 0 (CCL26 protein, human) RN - 0 (Chemokine CCL1) RN - 0 (Chemokine CCL26) RN - 0 (Chemokines, CC) RN - 0 (NGF protein, human) RN - 37341-29-0 (Immunoglobulin E) RN - 7171WSG8A2 (BDNF protein, human) RN - 9061-61-4 (Nerve Growth Factor) SB - IM MH - Aged MH - Biomarkers, Tumor/*blood MH - Brain-Derived Neurotrophic Factor/blood MH - Case-Control Studies MH - Chemokine CCL1/*blood MH - Chemokine CCL26 MH - Chemokines, CC/*blood MH - Female MH - Humans MH - Immunoglobulin E/*blood MH - Lymphoma, T-Cell, Cutaneous/blood/complications/*immunology/pathology MH - Male MH - Middle Aged MH - Mycosis Fungoides/blood/immunology MH - Nerve Growth Factor/*blood MH - Pruritus/*immunology/pathology MH - Sezary Syndrome/blood/immunology MH - Skin/*innervation/pathology MH - Skin Neoplasms/blood/complications/*immunology/pathology EDAT- 2012/09/06 06:00 MHDA- 2013/09/26 06:00 CRDT- 2012/09/06 06:00 PHST- 2012/09/06 06:00 [entrez] PHST- 2012/09/06 06:00 [pubmed] PHST- 2013/09/26 06:00 [medline] AID - 10.2340/00015555-1428 [doi] PST - ppublish SO - Acta Derm Venereol. 2013 Mar 27;93(2):144-9. doi: 10.2340/00015555-1428.